News

404

Immunophotonics Announces Appointment of New Chief Medical Officer and Chief Scientific Officer

Immunophotonics Announces Appointment of New Chief Medical Officer and Chief Scientific Officer

Immunophotonics, Inc. is thrilled to announce the addition of Dr. Edwina Baskin-Bey in the role of Chief Medical Office (CMO) and Dr. David Anderson in the role of Chief Scientific Officer (CSO).  Dr. Baskin-Bey’s vast experience in leading global clinical development and regulatory strategy across multiple therapeutic areas will strengthen the clinical development program as the company expands into Phase 2 trials and beyond.  Dr. Anderson’s proven experience in innovation, which includes facilitating asset development from discovery through approval, will allow Immunophotonics to bolster its research and development initiatives.  Read More

Scroll to top